Patents Examined by Maurie Garcia Baker
  • Patent number: 6670298
    Abstract: The present invention relates, inter alia, to methodologies for the synthesis, screening and characterization of organometallic compounds and catalysts (e.g., homogeneous catalysts). The methods of the present invention provide for the combinatorial synthesis, screening and characterization of libraries of supported and unsupported organometallic compounds and catalysts (e.g., homogeneous catalysts). The methods of the present invention can be applied to the preparation and screening of large numbers of organometallic compounds which can be used not only as catalysts (e.g., homogeneous catalysts), but also as additives and therapeutic agents.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: December 30, 2003
    Assignee: Symyx Technologies, Inc.
    Inventors: W. Henry Weinberg, Eric McFarland, Isy Goldwasser, Thomas Boussie, Howard Turner, Johannes A. M. Van Beek, Vince Murphy, Timothy Powers
  • Patent number: 6667406
    Abstract: Disclosed are methods of synthesizing libraries of diverse complex hexahydroisoindole, hexahydroisooxyindole and octahydroisooxyquinoline compounds through the use of a facile intramolecular Diels Alder reaction. The invention is further directed to methods for synthesizing the libraries on solid supports. The invention is further directed to methods for identifying and isolating such hexahydroisoindole, hexahydroisooxyindole and octahydroisooxyquinoline compounds with useful and diverse activities from such libraries.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: December 23, 2003
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Sengen Sun, William V. Murray
  • Patent number: 6664372
    Abstract: Peptidomimetic azatides and combinatorial oligoazitide libraries are produced by means of a stepwise synthesis. Combinatorial library construction of this new biomimetic polymer provides a means to fabricate global peptidomimetic libraries.
    Type: Grant
    Filed: September 1, 1998
    Date of Patent: December 16, 2003
    Assignee: The Scripps Research Institute
    Inventors: Kim D. Janda, Hyunsoo Han
  • Patent number: 6663869
    Abstract: A homogeneous polyoxime composition is provided, in which the polyoxime molecules present comprise a first organic baseplate molecule, which is a polypeptide, wherein the baseplate molecule is linked to at least two second organic molecules, which may be the same or different from one another. In the compositions, the linkages between the baseplate and said organic molecules are oxime linkages formed by reaction of an orthogonal reactive group on each the organic molecules with a complementary orthogonal reactive group on the baseplate.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: December 16, 2003
    Assignee: Gryphon Therapeutics, Inc.
    Inventors: Keith Rose, Robin E. Offord
  • Patent number: 6660466
    Abstract: Compositions comprising novel di-nitrogen heterocycle compounds containing at least one N-meta-substituted alkaryl group are prepared. The compounds of the present invention are useful as antibacterial and as other pharmaceutical agents and as intermediates for preparation of other pharmaceutical agents. In addition, compounds of the present invention are useful as research reagents.
    Type: Grant
    Filed: August 3, 1998
    Date of Patent: December 9, 2003
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Phillip Dan Cook, Pei-Pei Kung, Andrew Mamoru Kawasaki
  • Patent number: 6656694
    Abstract: A method of identifying a ligand for a second binding site (5) on a biological substrate (1) is disclosed. The method comprises determining the effect of a candidate compound (9) on the binding of a probe compound (2) which binds to a first binding site (3) on the biological substrate in the presence of a first multibinding compound (4) which binds to the first (3) and second (5) binding sites on the biological substrate (1).
    Type: Grant
    Filed: January 11, 2001
    Date of Patent: December 2, 2003
    Assignee: Theravance, Inc.
    Inventor: Mathai Mammen
  • Patent number: 6656739
    Abstract: Disclosed are methods for screening compound libraries using frontal chromatography in combination with mass spectrometry to identify and rank those members of the library that bind to a target receptor. Methods are also disclosed which permit a compound library to be rapidly screened to determine if any members of the library have a higher affinity for the target receptor relative to a pre-selected indicator compound.
    Type: Grant
    Filed: April 24, 2001
    Date of Patent: December 2, 2003
    Inventors: Ole Hindsgaul, David C. Schriemer
  • Patent number: 6653138
    Abstract: A method and system for researching and developing and/or optimizing new catalysts and products in a combinatorial manner is disclosed. The method begins with starting components or a ligand library and provides methods of creating catalyst or product libraries, which are then tested in a reaction of interest. The system uses methods of robotic handling for moving libraries from station to station. The method and apparatus are especially useful for synthesizing, screening, and characterizing combinatorial catalyst libraries, but also offer significant advantages over conventional experimental methods as well.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: November 25, 2003
    Assignee: Symyx Technologies, Inc.
    Inventors: Howard W. Turner, Lynn VanErden, G. Cameron Dales, Adam Safir, Ralph B. Nielsen
  • Patent number: 6649415
    Abstract: Disclosed are methods for screening compound libraries using frontal chromatography in combination with mass spectrometry to identify and rank those members of the library that bind to a target receptor. Methods are also disclosed which permit a compound library to be rapidly screened to determine if any member of the library has an affinity for the target receptor as measured by a pre-selected indicator compound.
    Type: Grant
    Filed: September 18, 2000
    Date of Patent: November 18, 2003
    Inventors: Ole Hindsgaul, David C. Schriemer
  • Patent number: 6635764
    Abstract: This invention relates to urea compounds that are muscarinic receptor antagonists and agonists, pharmaceutical compositions comprising such compounds, and methods of preparing these compounds.
    Type: Grant
    Filed: December 7, 2000
    Date of Patent: October 21, 2003
    Assignee: Theravance, Inc.
    Inventors: Mathai Mammen, David Oare
  • Patent number: 6627453
    Abstract: Disclosed are methods for screening compound libraries using frontal chromatography in combination with mass spectrometry to identify and rank those members of the library that bind to a target receptor. Methods are also disclosed which permit a compound library to be rapidly screened to determine if any member of the library has an affinity for the target receptor as measured by a pre-selected indicator compound.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: September 30, 2003
    Inventors: Ole Hindsgaul, David C. Schriemer
  • Patent number: 6627748
    Abstract: This invention provides a combinatorial fluorescence energy transfer tag which comprises a plurality of fluorescent molecules, comprising one or more energy transfer donor and one or more energy transfer acceptor, linked through a molecular scaffold wherein the fluorescent molecules are separated along the scaffold to produce a unique fluorescence emission signature. The invention further provides for the use of said tags in multi-component analyses, including multiplex genetic analyses.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: September 30, 2003
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Jingyue Ju, Zengmin Li, Anthony Tong, James J. Russo
  • Patent number: 6613575
    Abstract: Disclosed are methods for screening compound libraries using frontal chromatography in combination with mass spectrometry to identify and rank those members of the library that bind to a target receptor. Methods are also disclosed which permit a compound library to be rapidly screened to determine if any members of the library have a higher affinity for the target receptor relative to a pre-selected indicator compound.
    Type: Grant
    Filed: May 15, 2000
    Date of Patent: September 2, 2003
    Inventors: Ole Hindsgaul, David C. Schriemer
  • Patent number: 6576793
    Abstract: Disclosed are multibinding compounds which are &bgr;2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma and bronchitis. They are also useful in the treatment of nervous system injury and premature labor.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: June 10, 2003
    Assignee: Theravance, Inc.
    Inventors: Edmund J. Moran, John H. Griffin, Seok-Ki Choi
  • Patent number: 6486354
    Abstract: Embodiments of the present invention generally relate to carrying out organic chemistry on solid supports comprising derivatised functionalities, methods for synthesizing said supports, methods for synthesizing compounds comprising amine groups or N-containing heterocycles using said solid supports, intermediate compounds linked to said supports and uses thereof.
    Type: Grant
    Filed: April 17, 2000
    Date of Patent: November 26, 2002
    Assignee: Akzo Nobel N.V.
    Inventors: David Gani, Friedrich Erich Karl Kroll, Michael John Plater, John Richard Morphy, David Rees